申请人:Janssen Pharmaceutica N.V.
公开号:US04219559A1
公开(公告)日:1980-08-26
Novel N-heterocyclyl-4-piperidinamines wherein said heterocyclic radical is an optionally substituted 1H-benzimidazol-2-yl or 3H-imidazo[4,5-b]pyridin-2-yl radical, said compounds being useful as antihistaminic agents.
新型N-杂环基-4-哌啶胺,其中所述的杂环基是可选择地取代的1H-苯并咪唑-2-基或3H-咪唑并[4,5-b]吡啶-2-基基团,所述化合物可用作抗组胺药物。